Cargando…
The Evaluation of Meropenem Dosing Regimens Against ESBL-Producing Escherichia coli in ICU Patients Using Monte Carlo Simulation
PURPOSE: To evaluate the optimal dosing regimens of meropenem against extended-spectrum beta-lactamase-producing Escherichia coli (ESBL E. coli) in critically ill patients with varying degrees of renal function using Monte Carlo simulation (MCS). METHODS: The MCS was performed using the minimum inhi...
Autores principales: | Win, Ei Ei, Htun, Khaing Win, Tragulpiankit, Pramote, Tangtrakultham, Suwida, Montakantikul, Preecha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846559/ https://www.ncbi.nlm.nih.gov/pubmed/35177911 http://dx.doi.org/10.2147/IDR.S345385 |
Ejemplares similares
-
Colistin Dosing Regimens against Pseudomonas aeruginosa in Critically Ill Patients: An Application of Monte Carlo Simulation
por: Nguyen, Van Thi Khanh, et al.
Publicado: (2021) -
Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation
por: Leelawattanachai, Pannee, et al.
Publicado: (2020) -
Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
por: Song, Xiangqing, et al.
Publicado: (2019) -
Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
por: Lertwattanachai, Tospon, et al.
Publicado: (2020) -
Pharmacokinetics and Monte Carlo Simulation of Meropenem in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2021)